Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy SystemsBusiness Wire • 10/17/22
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022Business Wire • 10/12/22
Why Is Cardiovascular Systems (CSII) Down 18.9% Since Last Earnings Report?Zacks Investment Research • 09/01/22
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial ResultsBusiness Wire • 08/03/22
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022Business Wire • 07/13/22
Cardiovascular Systems (CSII) Up 0.9% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/03/22
Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/08/22
Cardiovascular Systems (CSII) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 05/04/22
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial ResultsBusiness Wire • 05/04/22
Cardiovascular Systems (CSII) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 04/27/22
Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare ConferencesBusiness Wire • 03/22/22
Cardiovascular Systems, Inc. Announces First In-Human Experience With Company's Propel™ Percutaneous Ventricular Assist DeviceBusiness Wire • 03/16/22
Cardiovascular Systems, Inc. Announces First In-Human Experience With Peripheral Everolimus Drug-Coated BalloonBusiness Wire • 03/09/22
Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy DevicesBusiness Wire • 02/23/22
Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/03/22